checkAd

    EQS-Adhoc  154  0 Kommentare Changes to the Board of Directors of HBM Healthcare Investments Ltd

    EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Annual Results
    Changes to the Board of Directors of HBM Healthcare Investments Ltd

    07-May-2021 / 07:18 CET/CEST
    Release of an ad hoc announcement pursuant to Art. 53 KR
    The issuer is solely responsible for the content of this announcement.


    Media Release

    Follow us on  img@HbmHealthcare

    Zug, 7 May 2021

    Board of Directors of HBM Healthcare Investments Ltd proposes Dr Elaine V. Jones, an experienced and well connected executive, to be elected to the Board of Directors at the Shareholders' Meeting on 18 June 2021. In this regard, the Company refers to its announcement of 2 November 2020. 

    Dr Jones has more than 20 years of investment experience in venture capital financing, focusing on biosciences. For more than ten years, she was vice-president at Pfizer Ventures with responsibility for managing investments in biotechnology and healthcare companies. Prior to that, Dr Jones worked at EuclidSR Partners and at SR One, the former venture capital fund of GlaxoSmithKline.

    The three long-standing members of the Board of Directors, Prof. Dr Heinz Riesenhuber (Vice Chairman), Dr Eduard E. Holdener and Robert A. Ingram, are retiring and therefore not standing for re-election at the forthcoming Shareholders' Meeting . 

    'Over the last two decades, Heinz, Ed and Bob have been instrumental in establishing and building up our company. On behalf of the Board of Directors and the Mangement I thank them for their valuable services and enormous commitment  over the years and wish them all the best for their personal future. At the same time, we are looking forward to working with Elaine Jones and the other The existing directors Ruedi Lanz, Germano Giuliani and Stella Xu.' comments Chairman Hans Peter Hasler.

    Contact
    For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



    End of ad hoc announcement
    Language: English
    Company: HBM Healthcare Investments AG
    Bundesplatz 1
    6300 Zug
    Switzerland
    Phone: +41438887171
    Fax: +41438887172
    E-mail: info@hbmhealthcare.com
    Internet: https://www.hbmhealthcare.com
    ISIN: CH0012627250
    Valor: 1262725
    Listed: SIX Swiss Exchange
    EQS News ID: 1193722

     
    End of Announcement EQS Group News Service

    1193722  07-May-2021 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1193722&application_name=news&site_id=wallstreet


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Changes to the Board of Directors of HBM Healthcare Investments Ltd EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Annual Results Changes to the Board of Directors of HBM Healthcare Investments Ltd 07-May-2021 / 07:18 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is …

    Schreibe Deinen Kommentar

    Disclaimer